肾细胞癌的分期：术前常规骨扫描的成本效益

Staging of renal cell carcinoma: cost-effectiveness of routine preoperative bone scans.

作者信息

Campbell R J, Broaddus S B, Leadbetter G W

出版信息

Urology. 1985 Mar;25(3):326-9. doi: 10.1016/0090-4295(85)90344-9.

Abstract

The use of bone scans in the evaluation of renal cell carcinoma has become routine in many centers. In a retrospective analysis of 42 patients undergoing radical nephrectomy for renal cell carcinoma, we analyzed the cost-effectiveness of routine preoperative bone scans. Although these scans accurately predict metastatic disease to bone, they are not cost-effective as a routine preoperative tool because they do not alter outcome. In selected patients with bone pain and no other positive staging studies, preoperative bone scans may be of value in the decision to perform extirpative surgery.

摘要

在许多医疗中心，使用骨扫描评估肾细胞癌已成为常规操作。在一项对42例行根治性肾切除术治疗肾细胞癌患者的回顾性分析中，我们分析了术前常规骨扫描的成本效益。尽管这些扫描能准确预测骨转移疾病，但作为常规术前检查手段，它们并不具有成本效益，因为它们并不能改变治疗结果。对于有骨痛且其他分期检查无阳性结果的特定患者，术前骨扫描可能有助于决定是否进行根治性手术。